Verastem VSTM
NASDAQ VSTM
$9.94 +0.73 (+7.93%)
As of: Oct 22, 2026 · 2:40 PM EDT

Verastem (VSTM) Short-Term Debt issuances (2023 - 2026)

Updated

Analysis

Verastem (VSTM) Short-Term Debt issuances (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Issuance (Qtr)
1 Eli Lilly 1,167.69 Bn 1,136.27 Bn 19.71 Bn -
2 Johnson & Johnson 648.01 Bn 567.87 Bn 17.30 Bn 2.28 Bn
3 AbbVie 503.52 Bn 476.63 Bn 12.70 Bn -
4 Merck 367.68 Bn 322.06 Bn 12.21 Bn -
5 Novartis Ag 303.32 Bn 267.31 Bn 11.24 Bn -
6 Astrazeneca 269.17 Bn 242.86 Bn 12.86 Bn -
7 Amgen 242.30 Bn 197.70 Bn 7.24 Bn -
8 Gilead Sciences 195.24 Bn 169.44 Bn 6.22 Bn -
9 Pfizer 172.59 Bn 119.24 Bn 10.94 Bn -
10 Verastem 991.65 Mn 348.28 Mn 36.32 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 736,000.00
Mar 31, 2025 1.18 Mn
Mar 31, 2024 1.30 Mn
Mar 31, 2023 1.43 Mn
API Access

Verastem Short-Term Debt issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-issuances&ticker=VSTM&period=max&api_key=YOUR_API_KEY